Ebola hemorrhagic fever
Ebola hemorrhagic fever
Explore linked clinical trials. Standard reference: MONDO:00057379 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT07842107 | |
| A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-21 | NCT07565090 | |
| Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - DRC | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Not stated | 2026-07-07 | NCT07688083 | |
| Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA | Arenaviridae infectious disease, Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Lassa fever, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Not stated | 2026-07-02 | NCT07681752 | |
| REVIVE (Response to the Ebola Virus Vaccine) | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 4 | 2026-06-04 | NCT05992480 | |
| EBOla Post-Exposure Prophylaxis | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 3 | 2026-01-22 | NCT06841614 | |
| Immunology of Ebola Vaccine | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 2 | 2026-01-22 | NCT06100913 | |
| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 | 2026-01-22 | NCT05202288 | |
| Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 3 | 2025-03-18 | NCT06126822 |